Kidswell Bio Corporation (TYO:4584)
274.00
+9.00 (3.40%)
At close: Mar 6, 2026
Kidswell Bio Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 |
Cash & Equivalents | 3,785 | 2,995 | 1,187 | 1,461 | 2,032 | 2,009 |
Cash & Short-Term Investments | 3,785 | 2,995 | 1,187 | 1,461 | 2,032 | 2,009 |
Cash Growth | - | 152.32% | -18.75% | -28.10% | 1.13% | 6.25% |
Accounts Receivable | 473.33 | 1,267 | 461 | 816 | 651 | 559.26 |
Other Receivables | - | 50 | - | - | - | - |
Receivables | 473.33 | 1,317 | 461 | 816 | 651 | 559.26 |
Inventory | 616.68 | 1,475 | 988 | 450 | 254 | 11.93 |
Prepaid Expenses | - | 16 | - | - | - | 14.67 |
Other Current Assets | 1,189 | 897 | 689 | 619 | 385 | 226.49 |
Total Current Assets | 6,063 | 6,700 | 3,325 | 3,346 | 3,322 | 2,822 |
Property, Plant & Equipment | 1.09 | 1 | 1 | 3 | 1 | 1.1 |
Long-Term Investments | 236.98 | 305 | 172 | 581 | 267 | 322.57 |
Other Intangible Assets | 0.68 | - | 3 | 2 | - | 0.1 |
Other Long-Term Assets | 17.56 | 2 | 2 | 1 | 2 | 5.88 |
Total Assets | 6,320 | 7,008 | 3,503 | 3,933 | 3,592 | 3,151 |
Accounts Payable | 65.75 | 226 | 45 | 109 | 8 | 56.74 |
Accrued Expenses | - | - | - | - | - | 319.06 |
Short-Term Debt | - | - | - | - | 25 | - |
Current Portion of Long-Term Debt | 300 | 657 | 75 | - | - | - |
Current Income Taxes Payable | - | 453 | 297 | 396 | 255 | 22.53 |
Other Current Liabilities | 401.15 | 2,982 | 711 | 609 | 592 | 1.83 |
Total Current Liabilities | 1,977 | 4,318 | 1,128 | 1,114 | 880 | 400.16 |
Long-Term Debt | 2,325 | 1,180 | 625 | 1,100 | 1,200 | - |
Pension & Post-Retirement Benefits | 49.52 | 41 | 31 | 19 | 19 | 19.23 |
Long-Term Deferred Tax Liabilities | 42.24 | 56 | - | 89 | - | 0.7 |
Other Long-Term Liabilities | 0 | 4 | 2 | 2 | 6 | 0 |
Total Liabilities | 4,394 | 5,599 | 1,786 | 2,324 | 2,105 | 420.09 |
Common Stock | 189.45 | 2,317 | 1,421 | 1,032 | 611 | 591.34 |
Additional Paid-In Capital | 2,564 | 11,623 | 10,726 | 10,337 | 9,917 | 3,864 |
Retained Earnings | -970.03 | -12,730 | -10,613 | -10,078 | -9,077 | -1,761 |
Comprehensive Income & Other | 142.27 | 199 | 183 | 318 | 36 | 36.46 |
Shareholders' Equity | 1,926 | 1,409 | 1,717 | 1,609 | 1,487 | 2,731 |
Total Liabilities & Equity | 6,320 | 7,008 | 3,503 | 3,933 | 3,592 | 3,151 |
Total Debt | 2,625 | 1,837 | 700 | 1,100 | 1,225 | - |
Net Cash (Debt) | 1,160 | 1,158 | 487 | 361 | 807 | 2,009 |
Net Cash Growth | - | 137.78% | 34.90% | -55.27% | -59.84% | 6.25% |
Net Cash Per Share | 23.38 | 28.59 | 15.79 | 12.54 | 29.19 | 102.88 |
Filing Date Shares Outstanding | 49.6 | 47.63 | 31.44 | 29.94 | 28.73 | 20.34 |
Total Common Shares Outstanding | 49.6 | 43.88 | 31.44 | 29.62 | 27.65 | 20.34 |
Working Capital | 4,087 | 2,382 | 2,197 | 2,232 | 2,442 | 2,422 |
Book Value Per Share | 38.83 | 32.11 | 54.62 | 54.32 | 53.79 | 134.26 |
Tangible Book Value | 1,925 | 1,409 | 1,714 | 1,607 | 1,487 | 2,731 |
Tangible Book Value Per Share | 38.81 | 32.11 | 54.52 | 54.25 | 53.79 | 134.26 |
Buildings | - | - | - | - | - | 2.05 |
Machinery | - | - | - | - | - | 4.99 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.